Among these sites, 488 sites were edited in A172 glioblastoma cells according to our criteria (S2 Table), and about half of those editing sites (261 sites) showed more than 5% increase of the average editing levels after IFN stimulation (Fig 2D and 2E). The gene discussed is IFNA1; the disease is glioblastoma.